Author

Ravi Chandra Yada

Observed names: Ravi C. Yada, Ravi Yada

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Observed institutions: National Institutes of Health, University of Wisconsin–Madison, University of Illinois Urbana-Champaign, University of Wisconsin Carbone Cancer Center, National Heart, Lung, and Blood Institute

ORCID: 0000-0002-5385-1728

Observed ORCID: 0000-0002-5385-1728

OpenAlex ID: A5080856494

Combinatorial microenvironmental regulation of liver progenitor differentiation by Notch ligands, TGFβ and extracellular matrix

2016 · Kerim B. Kaylan, Viktoriya Ermilova, et al. · Scientific Reports · 48

PDF

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment

2022 · Nan Sethakorn, Erika Heninger, et al. · Cancers · 33

PDF

Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers

2017 · So Gun Hong, Ravi Chandra Yada, et al. · Molecular Therapy · 32

PDF

Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism

2023 · Ravi Chandra Yada, Danielle E. Desa, et al. · Biomaterials · 29

Efficient differentiation of cardiomyocytes and generation of calcium-sensor reporter lines from nonhuman primate iPSCs

2018 · Yongshun Lin, Huimin Liu, et al. · Scientific Reports · 27

PDF

Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response

2025 · Cristina Sánchez-de-Diego, Ravi Chandra Yada, et al. · Communications Biology · 16

PDF

CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes

2020 · John W. Ostrominski, Ravi Chandra Yada, et al. · Stem Cells Translational Medicine · 15

PDF

The effect of whole blood logistics on neutrophil non-specific activation and kinetics ex vivo

2024 · Chao Li, Mehtab Farooqui, et al. · Scientific Reports · 10

PDF

CRISPR/Cas9‐Based Safe‐Harbor Gene Editing in Rhesus iPSCs

2017 · Ravi Chandra Yada, John W. Ostrominski, et al. · Current Protocols in Stem Cell Biology · 9

Rhesus Macaque iPSC Generation and Maintenance

2017 · Ravi Chandra Yada, So Gun Hong, et al. · Current Protocols in Stem Cell Biology · 8

Micro blood analysis technology (μBAT): multiplexed analysis of neutrophil phenotype and function from microliter whole blood samples

2024 · Terry D. Juang, Jeremiah Riendeau, et al. · Lab on a Chip · 4

PDF

MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasis

2025 · Deri Morgan, Dakota DD. Okwuone, et al. · Cancer Letters · 3

Multimodal Imaging and Theranostic Application of Disease-Directed Agents

2015 · Joseph Caffarini, Nathan Kelleher, et al. · Topics in medicinal chemistry · 2

Abstract 635: Osteoclasts mediate chemotherapy resistance in a fully humanized microphysiologic system of prostate cancer bone metastases

2024 · Adeline B. Ding, Erika Heninger, et al. · Cancer Research · 1

Abstract A069: Microscale modeling of the human prostate bone metastatic niche

2023 · Adeline Ding, Cristina Sanchez de Diego, et al. · Cancer Research

Abstract 193: CRISPR-mediated Introduction of the Sodium-iodide Symporter to Enable Non-invasive Monitoring of Macaque Induced-pluripotent Stem Cell-derived Cardiomyocytes

2017 · John Ostrominski, Ravi Chandra Yada, et al. · Circulation Research

527. Improvement of Pre-Clinical Non-Human Primate Model for Pluripotent Stem Cell Based Therapies by Introducing Marker Genes in Safe Harbor Locus

2016 · Ravi Chandra Yada, So Gun Hong, et al. · Molecular Therapy

PDF

Works count: 17

Citation count: 236

H-index: 9

I10-index: 8